FDG-PET after two to three cycles of chemotherapy predicts progression-free and overall survival in high-grade non-Hodgkin lymphoma.

Source:http://linkedlifedata.com/resource/pubmed/id/15980161

Download in:

View as

General Info

PMID
15980161